(Q47827080)

6 February 2018

title

Rapid accurate field diagnosis of Indian visceral leishmaniasis. (English)

1 reference

6 February 2018

main subject

visceral leishmaniasis

1 reference

1

S Sundar

1 reference

6 February 2018

S G Reed

2

1 reference

6 February 2018

V P Singh

series ordinal

3

1 reference

6 February 2018

P C Kumar

series ordinal

4

1 reference

6 February 2018

H W Murray

series ordinal

5

1 reference

6 February 2018

language of work or name

English

0 references

publication date

1 February 1998

1 reference

6 February 2018

published in

The Lancet

1 reference

6 February 2018

volume

351

1 reference

6 February 2018

issue

9102

1 reference

6 February 2018

page(s)

563-565

1 reference

6 February 2018

Estimation of population at risk of infection and number of cases of Leishmaniasis

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2904350-X

7 January 2021

Clinical spectrum of Leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2904350-X

7 January 2021

A rapid and simple diagnostic test for active visceral leishmaniasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2904350-X

7 January 2021

Kala-azar: a comparative study of parasitological methods and the direct agglutination test in diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2904350-X

7 January 2021

rK39: A Cloned Antigen of Leishmania chagasi that Predicts Active Visceral Leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2904350-X

7 January 2021

Comparison of PCR with direct examination of bone marrow aspiration, myeloculture, and serology for diagnosis of visceral Leishmaniasis in immunocompromised patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2904350-X

7 January 2021

Molecular characterization of a kinesin-related antigen of Leishmania chagasi that detects specific antibody in African and American visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2904350-X

7 January 2021

Serodiagnosis of Asian leishmaniasis with a recombinant antigen from the repetitive domain of a Leishmania kinesin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2904350-X

7 January 2021

Diagnostic and prognostic value of K39 recombinant antigen in Indian leishmaniasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2904350-X

7 January 2021

Immunochemotherapy for a systemic intracellular infection: accelerated response using interferon-gamma in visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2904350-X

7 January 2021

Short-course, low-dose amphotericin B lipid complex therapy for visceral leishmaniasis unresponsive to antimony.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2904350-X

7 January 2021

Immunochemotherapy for visceral leishmaniasis: a controlled pilot trial of antimony versus antimony plus interferon-gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2904350-X

7 January 2021

New perspectives on a subclinical form of visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2904350-X

7 January 2021

Prevalence and disease spectrum in a new focus of visceral leishmaniasis in Kenya

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2904350-X

7 January 2021

Use of the leishmanin skin test and western blot analysis for epidemiological studies in visceral leishmaniasis areas: experience in a highly endemic focus in Alpes-Maritimes (France)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2904350-X

7 January 2021

Visceral leishmaniasis in HIV infection and AIDS: clinical features and response to therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2904350-X

7 January 2021

10.1016/S0140-6736(97)04350-X

Identifiers

DOI

1 reference

6 February 2018

1 reference

6 February 2018